Contrary to findings from observational studies which are inherently affected by bias, digoxin use in randomised controlled trials (RCTs) did not lead to excess mortality in our meta-analysis of 87 studies. There is evidence that digoxin can reduce heart failure-related deaths and hospitalizations. This has implications in treating concomitant atrial fibrillation and heart failure, with two RCTs currently underway to improve our evidence base.  

 In this interview, Asgher Champsi MD, and Alison L. Bailey MD, FACC discuss ESC Late-Breaker: DIG-META: Digoxin in heart failure and atrial fibrillation. 

 Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL